Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir and daclatasvir for treatment of hepatitis C in thalassemia major patients
IRCT2017052426097N2Phase 3Completed
- Sponsor
- Research Council of Iran University of Medical Sciences
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sofosbuvir and daclatasvir in hepatitis C virus infection, sponsored by Research Council of Iran University of Medical Sciences. Started Dec 2016; status: completed.
02
Drugs
sofosbuvirdaclatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on IRCT2017052426097N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017052426097N2.